BioXcel Therapeutics - 48 Year Dividend Yield History | BTAI

Historical dividend payout and yield for BioXcel Therapeutics (BTAI) since 1971. The current TTM dividend payout for BioXcel Therapeutics (BTAI) as of March 20, 2019 is $0.00. The current dividend yield for BioXcel Therapeutics as of March 20, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.161B $0.000B
BioXcel Therapeutics Inc. is a clinical stage biopharmaceutical company. It focuses on drug development which utilizes novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology. The company's product portfolio include BXCL501, a sublingual thin film formulation of dexmedetomidine designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. BioXcel Therapeutics Inc. is based in the United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.160B 13.29
Gilead Sciences (GILD) United States $83.533B 10.63
Bio-Techne Corp (TECH) United States $7.518B 50.65